RNU1-128P

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RNU1-128P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated RNU1-128P data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher RNU1-128P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU1-128P expression acts as an unfavorable survival marker.

PAAD are the cancer types where RNU1-128P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
PAADOSTertileAll0.2160.613.04018view →
Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

RNU1-128P–PAAD (OS)

Kaplan–Meier survival curve for RNU1-128P RNA-high vs -low samples in PAAD.

Open the PAAD breakdown →

Exploration